| Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome J Wechsler, M Greene, MA McDevitt, J Anastasi, JE Karp, MM Le Beau, ... Nature genetics 32 (1), 148-152, 2002 | 852 | 2002 |
| A lineage‐selective knockout establishes the critical role of transcription factor GATA‐1 in megakaryocyte growth and platelet development RA Shivdasani, Y Fujiwara, MA McDevitt, SH Orkin The EMBO journal, 1997 | 851 | 1997 |
| Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms AM Jankowska, H Szpurka, RV Tiu, H Makishima, M Afable, J Huh, ... Blood, The Journal of the American Society of Hematology 113 (25), 6403-6410, 2009 | 457 | 2009 |
| Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A AM Jankowska, H Makishima, RV Tiu, H Szpurka, Y Huang, F Traina, ... Blood, The Journal of the American Society of Hematology 118 (14), 3932-3941, 2011 | 368 | 2011 |
| 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in … AJ Dunbar, LP Gondek, CL O'Keefe, H Makishima, MS Rataul, H Szpurka, ... Cancer research 68 (24), 10349-10357, 2008 | 336 | 2008 |
| Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide SR McCurdy, JA Kanakry, MM Showel, HL Tsai, J Bolaños-Meade, ... Blood, The Journal of the American Society of Hematology 125 (19), 3024-3031, 2015 | 303 | 2015 |
| Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia JE Farrar, M Nater, E Caywood, MA McDevitt, J Kowalski, CM Takemoto, ... Blood, The Journal of the American Society of Hematology 112 (5), 1582-1592, 2008 | 289 | 2008 |
| Somatic SETBP1 mutations in myeloid malignancies H Makishima, K Yoshida, N Nguyen, B Przychodzen, M Sanada, Y Okuno, ... Nature genetics 45 (8), 942-946, 2013 | 282 | 2013 |
| A “knockdown” mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1 MA McDevitt, RA Shivdasani, Y Fujiwara, H Yang, SH Orkin Proceedings of the National Academy of Sciences 94 (13), 6781-6785, 1997 | 272 | 1997 |
| Requirement of a downstream sequence for generation of a poly (A) addition site MA McDevitt, MJ Imperiale, H Ali, JR Nevins Cell 37 (3), 993-999, 1984 | 260 | 1984 |
| Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies C O'Keefe, MA McDevitt, JP Maciejewski Blood, The Journal of the American Society of Hematology 115 (14), 2731-2739, 2010 | 257 | 2010 |
| Kruppel-like factor 4 is essential for inflammatory monocyte differentiation in vivo JK Alder, RW Georgantas, RL Hildreth, IM Kaplan, S Morisot, X Yu, ... The Journal of Immunology 180 (8), 5645-5652, 2008 | 255 | 2008 |
| Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults YL Kasamon, J Bolaños-Meade, GT Prince, HL Tsai, SR McCurdy, ... Journal of Clinical Oncology 33 (28), 3152, 2015 | 251 | 2015 |
| Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies H Makishima, H Cazzolli, H Szpurka, A Dunbar, R Tiu, J Huh, ... Journal of clinical oncology 27 (36), 6109, 2009 | 246 | 2009 |
| Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies RV Tiu, LP Gondek, CL O'Keefe, P Elson, J Huh, A Mohamedali, ... Blood, The Journal of the American Society of Hematology 117 (17), 4552-4560, 2011 | 237 | 2011 |
| Novel homo-and hemizygous mutations in EZH2 in myeloid malignancies H Makishima, AM Jankowska, RV Tiu, H Szpurka, Y Sugimoto, Z Hu, ... Leukemia 24 (10), 1799-1804, 2010 | 221 | 2010 |
| Telomerase inhibitor imetelstat in patients with essential thrombocythemia GM Baerlocher, E Oppliger Leibundgut, OG Ottmann, G Spitzer, ... New England Journal of Medicine 373 (10), 920-928, 2015 | 208 | 2015 |
| Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS CG Kanakry, HL Tsai, J Bolaños-Meade, BD Smith, I Gojo, JA Kanakry, ... Blood, The Journal of the American Society of Hematology 124 (25), 3817-3827, 2014 | 203 | 2014 |
| Sequences capable of restoring poly (A) site function define two distinct downstream elements. MA McDevitt, RP Hart, WW Wong, JR Nevins The EMBO Journal 5 (11), 2907-2913, 1986 | 202 | 1986 |
| CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia H Makishima, AM Jankowska, MA McDevitt, C O'Keefe, S Dujardin, ... Blood, The Journal of the American Society of Hematology 117 (21), e198-e206, 2011 | 185 | 2011 |
